Tesla CEO Elon Musk announced that the electric vehicle giant will collaborate with major chipmakers TSMC and Samsung to manufacture its upcoming AI5 chip, designed to power Tesla’s next-generation Full Self-Driving (FSD) technology and Optimus robot. Musk emphasized that production will take place at both companies’ U.S. facilities, with the goal of ensuring an “oversupply” of AI5 chips to support future data center needs.
The AI5 chip represents a major step in Tesla’s push toward self-reliant AI infrastructure. Despite its in-house chip development, Musk clarified that Tesla does not plan to replace NVIDIA (NASDAQ: NVDA) as a supplier for its data centers. Instead, the company will continue using Nvidia hardware alongside Tesla’s own chips, similar to how it currently operates with the AI4 chip. Musk added that any excess AI5 production could be repurposed for Tesla’s expanding data operations.
Earlier this year, Tesla reportedly signed a $16.5 billion AI chip deal with Samsung, reinforcing its commitment to scaling up AI and FSD capabilities. Musk described the AI5 as “at least 40 times faster” than the AI4 and highlighted its superior efficiency and cost performance, stating it could deliver “the best performance per watt and per dollar for AI.”
This announcement comes after Tesla reported a weaker-than-expected third quarter, as rising trade tariffs and AI research expenses offset record-high revenue. Investors were also cautious, with shares dropping around 4% in after-hours trading.
Despite short-term challenges, Musk reaffirmed Tesla’s long-term vision centered around AI, autonomous driving, and robotics. The company’s robotaxi pilot program in Austin, Texas, is set to expand to other major cities by year’s end—underscoring Tesla’s continued leadership in AI-driven mobility innovation.


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



